Bos taurus adrenal cortex corticosteroids
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
3874 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Asthma | D001249 | EFO_0000270 | J45 | 23 | 96 | 100 | 92 | 187 | 487 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 14 | 13 | 48 | 40 | 65 | 177 |
| Kidney transplantation | D016030 | — | — | 7 | 33 | 26 | 42 | 11 | 113 |
| Lung diseases | D008171 | EFO_0003818 | J98.4 | 2 | 11 | 46 | 22 | 26 | 106 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | 12 | 17 | 14 | 22 | 46 | 104 |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | 10 | 16 | 18 | 26 | 38 | 103 |
| Obstructive lung diseases | D008173 | — | — | 6 | 9 | 36 | 21 | 29 | 100 |
| Atopic dermatitis | D003876 | EFO_0000274 | L20 | 1 | 13 | 33 | 18 | 28 | 92 |
| Covid-19 | D000086382 | — | U07.1 | 4 | 20 | 24 | 8 | 36 | 89 |
| Graft vs host disease | D006086 | — | D89.81 | 19 | 41 | 21 | 4 | 9 | 79 |
Show 435 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Bronchiolitis obliterans syndrome | D000092122 | — | D89.811 | 4 | 16 | 7 | — | 4 | 27 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 7 | 14 | 2 | — | 2 | 22 |
| Multiple myeloma | D009101 | — | C90.0 | 8 | 16 | 1 | — | — | 19 |
| Autoimmune diseases | D001327 | EFO_0000540 | M30-M36 | 3 | 3 | 5 | — | 8 | 18 |
| Alcoholic hepatitis | D006519 | EFO_1001345 | K70.1 | — | 4 | 7 | — | 7 | 17 |
| Hepatitis a | D006506 | EFO_0007305 | B15 | 1 | 8 | 5 | — | 5 | 15 |
| Burkitt lymphoma | D002051 | — | C83.7 | 1 | 11 | 3 | — | — | 14 |
| Non-small-cell lung carcinoma | D002289 | — | — | 2 | 9 | 5 | — | 1 | 14 |
| Back pain | D001416 | — | M54 | — | 1 | 1 | — | 11 | 13 |
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 5 | 11 | 1 | — | — | 12 |
Show 291 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| B-cell lymphoma | D016393 | — | — | 4 | 9 | — | — | — | 10 |
| Hematologic neoplasms | D019337 | — | — | 3 | 5 | — | — | — | 8 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 3 | 5 | — | — | 2 | 8 |
| Vulvar lichen sclerosus | D007724 | — | N90.4 | — | 1 | — | — | 6 | 7 |
| Adrenocortical carcinoma | D018268 | — | — | — | 4 | — | — | 2 | 6 |
| T-cell lymphoma | D016399 | — | — | 3 | 3 | — | — | — | 6 |
| Hyperaldosteronism | D006929 | — | E26 | 1 | 1 | — | — | 4 | 5 |
| Melanoma | D008545 | — | — | — | 4 | — | — | 1 | 5 |
| Hodgkin disease | D006689 | — | C81 | 1 | 3 | — | — | 1 | 5 |
| Aging | D000375 | GO_0007568 | R41.81 | — | 1 | — | — | 4 | 5 |
Show 195 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Intestinal diseases | D007410 | — | K63.9 | 1 | — | — | — | 8 | 9 |
| Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | 2 | — | — | — | 4 | 6 |
| Sleep wake disorders | D012893 | — | G47 | 1 | — | — | — | 3 | 4 |
| Psoriatic arthritis | D015535 | EFO_0003778 | L40.5 | 1 | — | — | — | 3 | 4 |
| Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | 1 | — | — | — | 2 | 3 |
| Blood pressure | D001794 | EFO_0004325 | — | 2 | — | — | — | 1 | 3 |
| Atherosclerosis | D050197 | EFO_0003914 | I25.1 | 1 | — | — | — | 2 | 3 |
| Cocaine-related disorders | D019970 | — | F14 | 2 | — | — | — | 1 | 3 |
| Sleep deprivation | D012892 | — | F51.12 | 2 | — | — | — | — | 2 |
| Pharmacokinetics | D010599 | — | — | 2 | — | — | — | — | 2 |
Show 47 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Uveomeningoencephalitic syndrome | D014607 | Orphanet_3437 | H20.82 | — | — | — | — | 5 | 5 |
| Mastitis | D008413 | EFO_1001034 | N61 | — | — | — | — | 5 | 5 |
| Granulomatous mastitis | D058890 | — | N61.2 | — | — | — | — | 4 | 4 |
| Hyaline membrane disease | D006819 | EFO_1000644 | P22.0 | — | — | — | — | 4 | 4 |
| Rehabilitation | D012046 | — | — | — | — | — | — | 4 | 4 |
| Myocardial infarction | D009203 | EFO_0000612 | I21 | — | — | — | — | 3 | 3 |
| Apnea | D001049 | — | R06.81 | — | — | — | — | 3 | 3 |
| Piriformis muscle syndrome | D055958 | — | — | — | — | — | — | 3 | 3 |
| Physical therapy modalities | D026741 | — | — | — | — | — | — | 3 | 3 |
| Bone fractures | D050723 | EFO_0003931 | T14.8 | — | — | — | — | 3 | 3 |
Show 283 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
204 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use